{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:28:20Z","timestamp":1788488900365,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA21130"],"award-info":[{"award-number":["CA21130"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"National Research Development and Innovation Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["RRF-2.3.1-21-2022-00011"],"award-info":[{"award-number":["RRF-2.3.1-21-2022-00011"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuropharm.2025.110566","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:04:31Z","timestamp":1750100671000},"page":"110566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting P2X7 mitigates neurobehavioural alterations in a mouse model of post-acute sequelae of SARS-CoV-2 infection"],"prefix":"10.1016","volume":"278","author":[{"given":"Dorottya","family":"Szab\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l","family":"Tod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fruzsina","family":"Ma\u00e1cz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00f3ra","family":"G\u00f6l\u00f6ncs\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadett","family":"Iring-Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibi\u00e1na","family":"T\u00f6r\u00f6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyula","family":"Zsidei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadett","family":"P\u00e1lyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Kis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be\u00e1ta","family":"Sperl\u00e1gh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110566_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1158460","article-title":"SARS-CoV-2 spike protein alters microglial purinergic signaling","volume":"14","author":"Alves","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110566_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/v15010114","article-title":"Mouse adapted SARS-CoV-2 (MA10) viral infection induces neuroinflammation in standard laboratory mice","volume":"15","author":"Amruta","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110566_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41386-019-0502-9","article-title":"Targeting neuroinflammation with brain penetrant P2X7 antagonists as novel therapeutics for neuropsychiatric disorders","volume":"45","author":"Bhattacharya","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110566_bib4","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00213-016-4214-0","article-title":"Role of neuro-immunological factors in the pathophysiology of mood disorders","volume":"233","author":"Bhattacharya","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110566_bib5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/bph.12314","article-title":"Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567","volume":"170","author":"Bhattacharya","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.neuropharm.2025.110566_bib6","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s41419-019-2110-3","article-title":"Positive allosteric modulation of P2X7 promotes apoptotic cell death over lytic cell death responses in macrophages","volume":"10","author":"Bidula","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110566_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11302-015-9493-0","article-title":"P2X ion channel receptors and inflammation","volume":"12","author":"Burnstock","year":"2016","journal-title":"Purinergic Signal."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110566_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm1603","article-title":"Identification of a key pathway required for the Sterile inflammatory response triggered by dying cells","volume":"13","author":"Chen","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2025.110566_bib9","series-title":"StatPearls","article-title":"Postacute coronavirus (COVID-19) syndrome","author":"Chippa","year":"2025"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110566_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41592-022-01447-w","article-title":"Animal models in SARS-CoV-2 research","volume":"19","author":"Chu","year":"2022","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110566_bib11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/01616412.1997.11740874","article-title":"Monofilament intraluminal middle cerebral artery occlusion in the mouse","volume":"19","author":"Clark","year":"1997","journal-title":"Neurol. Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2025.110566_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066547","article-title":"Neurochemical changes in the mouse hippocampus underlying the antidepressant effect of genetic deletion of P2X7 receptors","volume":"8","author":"Cs\u00f6lle","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.neuropharm.2025.110566_bib13","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00127-024-02655-9","article-title":"Anxiety and depression in people with post-COVID condition: a Belgian population-based cohort study three months after SARS-CoV-2 infection","volume":"59","author":"D'Hondt","year":"2024","journal-title":"Soc. Psychiatr. Psychiatr. Epidemiol."},{"key":"10.1016\/j.neuropharm.2025.110566_bib14","article-title":"Animal models of post-acute COVID-19 syndrome: a call for longitudinal animal studies","volume":"16","author":"Dai","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2025.110566_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/bs.mcb.2023.02.015","article-title":"A rigorous behavioral testing platform for the assessment of radiation-induced neurological outcomes","volume":"180","author":"Drayson","year":"2023","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.neuropharm.2025.110566_bib16","author":"Edouard Mathieu"},{"key":"10.1016\/j.neuropharm.2025.110566_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.concog.2023.103464","article-title":"COVID-19 infection does not seem to affect cognition in college students","volume":"108","author":"Francis","year":"2023","journal-title":"Conscious. Cognit."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110566_bib18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamapsychiatry.2022.1616","article-title":"Bridging knowledge gaps in the diagnosis and management of neuropsychiatric sequelae of COVID-19","volume":"79","author":"Frontera","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110566_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/21501319241254751","article-title":"Pro inflammatory cytokines profiles of patients with long COVID differ between variant epochs","volume":"15","author":"Ganesh","year":"2024","journal-title":"Journal of Primary Care & Community Health"},{"key":"10.1016\/j.neuropharm.2025.110566_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.894470","article-title":"Soluble P2X7 receptor is elevated in the plasma of COVID-19 patients and correlates with disease severity","volume":"13","author":"Garc\u00eda-Villalba","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110566_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185129","article-title":"Re-evaluation of the interrelationships among the behavioral tests in rats exposed to chronic unpredictable mild stress","volume":"12","author":"Hu","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.neuropharm.2025.110566_bib22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.immuni.2006.02.014","article-title":"IFN-Gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB\/AP-1 proteins","volume":"24","author":"Hu","year":"2006","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110566_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1211","article-title":"Post-COVID-19-associated multiorgan complications or \"long COVID\" with literature review and management strategy discussion: a meta-analysis","volume":"6","author":"Iqbal","year":"2023","journal-title":"Health Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110566_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.115020","article-title":"SARS-CoV-2 spike S1 protein induces microglial NLRP3-dependent neuroinflammation and cognitive impairment in mice","volume":"383","author":"Jiang","year":"2025","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110566_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41419-024-06642-5","article-title":"Research progress of post-acute sequelae after SARS-CoV-2 infection","volume":"15","author":"Jiao","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2025.110566_bib26","article-title":"COVID-19 induces neuroinflammation and loss of hippocampal neurogenesis","author":"Klein","year":"2021","journal-title":"Res Sq"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110566_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep36680","article-title":"The role of P2X7 receptors in a rodent PCP-Induced schizophrenia model","volume":"6","author":"Kov\u00e1nyi","year":"2016","journal-title":"Sci. Rep."},{"issue":"Pt B","key":"10.1016\/j.neuropharm.2025.110566_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2016.06.006","article-title":"Striatum on the anxiety map: small detours into adolescence","volume":"1654","author":"Lago","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110566_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1270081","article-title":"The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection","volume":"14","author":"L\u00e9cuyer","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110566_bib30","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.4103\/1673-5374.257510","article-title":"P2X7 receptor signaling during adult hippocampal neurogenesis","volume":"14","author":"Leeson","year":"2019","journal-title":"Neural Regen Res"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110566_bib31","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.cell.2020.09.050","article-title":"A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice","volume":"183","author":"Leist","year":"2020","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110566_bib32","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1021\/acsptsci.3c00127","article-title":"Emerging landscape of preclinical models for studying COVID-19 neurologic diseases","volume":"6","author":"Li","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"30","key":"10.1016\/j.neuropharm.2025.110566_bib33","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1523\/JNEUROSCI.3104-16.2017","article-title":"Neuronal P2X7 receptor: involvement in neuronal physiology and pathology","volume":"37","author":"Miras-Portugal","year":"2017","journal-title":"J. Neurosci."},{"issue":"21","key":"10.1016\/j.neuropharm.2025.110566_bib34","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1016\/j.neuron.2022.10.006","article-title":"The neurobiology of long COVID","volume":"110","author":"Monje","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110566_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.neuropharm.2025.110566_bib36","author":"Mukherjee"},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110566_bib37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110566_bib38","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1038\/s41598-022-09410-7","article-title":"SARS-CoV-2 spike protein induces cognitive deficit and anxiety-like behavior in mouse via non-cell autonomous hippocampal neuronal death","volume":"12","author":"Oh","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110566_bib39","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1038\/s41467-020-19891-7","article-title":"Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice","volume":"11","author":"Oladunni","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110566_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.662935","article-title":"Role of P2X7 receptors in immune responses during neurodegeneration","volume":"15","author":"Oliveira-Giacomelli","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110566_bib41","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neuropharm.2015.10.008","article-title":"Purinergic receptors in embryonic and adult neurogenesis","volume":"104","author":"Oliveira","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110566_bib42","author":"Organization"},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110566_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12960","article-title":"The potential involvement of P2X7 receptor in COVID-19 pathogenesis: a new therapeutic target?","volume":"93","author":"Pacheco","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.neuropharm.2025.110566_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.922422","article-title":"Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome","volume":"12","author":"Queiroz","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2025.110566_bib45","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41380-020-00965-3","article-title":"Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology","volume":"26","author":"Ribeiro","year":"2021","journal-title":"Mol. Psychiatr."},{"issue":"9","key":"10.1016\/j.neuropharm.2025.110566_bib46","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.4049\/jimmunol.1102048","article-title":"IL-1\u03b1 and IL-1\u03b2 recruit different myeloid cells and promote different stages of sterile inflammation","volume":"187","author":"Rider","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2025.110566_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.576955","article-title":"Chemoresistance in breast cancer patients associated with changes in P2X7 and A2A purinergic receptors in CD8(+) T lymphocytes","volume":"11","author":"Ruiz-Rodr\u00edguez","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2025.110566_bib48","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.neuropharm.2025.110566_bib49","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.4049\/jimmunol.161.8.4283","article-title":"Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-Gamma","volume":"161","author":"Shibata","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2025.110566_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1384516","article-title":"A murine model of post-acute neurological sequelae following SARS-CoV-2 variant infection","volume":"15","author":"Singh","year":"2024","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110566_bib51","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2014.08.002","article-title":"P2X7 receptor: an emerging target in central nervous system diseases","volume":"35","author":"Sperl\u00e1gh","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2025.110566_bib52","author":"Sriram"},{"key":"10.1016\/j.neuropharm.2025.110566_bib53","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbi.2022.01.015","article-title":"Maternal P2X7 receptor inhibition prevents autism-like phenotype in Male mouse offspring through the NLRP3-IL-1\u03b2 pathway","volume":"101","author":"Szab\u00f3","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.neuropharm.2025.110566_bib54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/pcn.13481","article-title":"Neurological post-acute sequelae of SARS-CoV-2 infection","volume":"77","author":"Takao","year":"2023","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110566_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1182454","article-title":"The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients","volume":"14","author":"Vultaggio-Poma","year":"2023","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.neuropharm.2025.110566_bib56","article-title":"Disentangling the cognitive, physical, and mental health sequelae of COVID-19","volume":"3","author":"Wild","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.neuropharm.2025.110566_bib57","series-title":"Stress: Immunology and Inflammation","first-page":"53","article-title":"Chapter 7 - interleukin-1 beta in psychosocial stress","author":"Yin","year":"2024"},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110566_bib58","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41380-022-01614-7","article-title":"A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action","volume":"28","author":"Zeng","year":"2023","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2025.110566_bib59","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41392-021-00719-9","article-title":"SARS-CoV-2 crosses the blood\u2013brain barrier accompanied with basement membrane disruption without tight junctions alteration","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825002722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T09:23:41Z","timestamp":1779614621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825002722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":59,"alternative-id":["S0028390825002722"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110566","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting P2X7 mitigates neurobehavioural alterations in a mouse model of post-acute sequelae of SARS-CoV-2 infection","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110566"}}